X-151623010-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_173493.3(PASD1):c.492G>C(p.Glu164Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000331 in 1,207,771 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173493.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111654Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.00000549 AC: 1AN: 182173 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000182 AC: 2AN: 1096117Hom.: 0 Cov.: 30 AF XY: 0.00000276 AC XY: 1AN XY: 361679 show subpopulations
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111654Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33828 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.492G>C (p.E164D) alteration is located in exon 7 (coding exon 6) of the PASD1 gene. This alteration results from a G to C substitution at nucleotide position 492, causing the glutamic acid (E) at amino acid position 164 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at